Antiproliferative effect induced by novel imidazoline S43126 in PC12 cells is mediated by ROS, stress activated MAPKs...

Area of Science:

• Pharmacology
• Cell Biology
• Biochemistry

Background:

• Imidazoline compounds exhibit diverse biological activities, including in vitro cell death induction.
• The novel imidazoline compound S43126 was investigated for its antiproliferative effects.
• The study explored the involvement of the I1-imidazoline receptor (I1R), reactive oxygen species (ROS), mitogen-activated protein kinases (MAPKs), and caspases in S43126-induced cell death.

Purpose of the Study:

• To evaluate the antiproliferative and pro-apoptotic actions of S43126 on PC12 cells.
• To elucidate the molecular mechanisms underlying S43126-induced cell death, focusing on I1R, ROS, MAPKs, and caspases.

Main Methods:

• PC12 cells were treated with S43126 at various concentrations.
• Effects on cell proliferation and apoptosis were assessed using Trypan Blue and Alamar Blue assays.
• ROS levels, Western blotting, microscopy, and specific inhibitors (efaroxan, N-acetyl-cysteine, MAPK inhibitors, z-VAD-fmk) were employed to investigate signaling pathways.

Main Results:

• S43126 significantly reduced PC12 cell proliferation (>50%) and increased cell death (>40%) with apoptotic body formation.
• These effects were antagonized by the I1R antagonist efaroxan, and ROS production (increased >2.5-fold) was inhibited by N-acetyl-cysteine.
• MAPK pathway activation (ERK, JNK, p38) and caspase activation (caspases 3, 8, 9) were observed, and their inhibition ameliorated S43126's effects.

Conclusions:

• S43126-induced PC12 cell death is partly mediated by ROS generation, MAPK, and caspase activation.
• These findings suggest a role for the I1-imidazoline receptor in apoptotic processes.
• S43126 represents a potential therapeutic agent targeting cell death pathways.